Results 11 to 20 of about 29,938 (169)
Vaccine success and challenges in northern Australia [PDF]
Microbiology Australia, 2022 Aboriginal and Torres Strait Islander people living in rural and remote Australia have lower vaccine coverage rates and experience higher rates of notification and hospitalisations for vaccine preventable diseases than non-Aboriginal people.
Rosalind Webby +2 more
doaj
Human Vaccines & Immunotherapeutics, 2020 Neisseria meningitidis can lead to invasive meningococcal disease to which young children are particularly vulnerable. We assessed the immunogenicity and safety of Sanofi Pasteur’s investigational quadrivalent (serogroups A, C, Y, and W) meningococcal ...
Timo Vesikari +5 more
doaj +1 more source
Scientific Reports, 2019 Between April 2016 and September 2017, four cases of group B meningococcal disease were reported among sixth-form college students in Bristol, UK. Culture and non-culture whole genome sequencing was utilised and demonstrated that the four genomes of the ...
Stephen A. Clark +13 more
doaj +1 more source
Human Vaccines & Immunotherapeutics, 2019 The 4-component vaccine 4CMenB, developed against invasive disease caused by meningococcal serogroup B, is approved for use in infants in several countries worldwide.
Alessia Biolchi +10 more
doaj +1 more source
mSphere, 2020 The molecular epidemiology of culture-confirmed invasive meningococcal disease (IMD) in Canada from 2010 to 2014 was studied with an emphasis on serogroup B Neisseria meningitidis (MenB) isolates, including their predicted coverage by the 4CMenB vaccine.
Raymond S. W. Tsang +9 more
doaj +1 more source
Expert Review of Vaccines, 2002 The successful introduction of a protein-polysaccharide conjugate vaccine against serogroup C meningococci into the UK infant immunization schedule, in combination with a catch-up campaign for individuals less than 18 years of age, has seen virtually all group C disease eliminated in childhood.
Bethell, D, Pollard, A
openaire +2 more sources
Increasing awareness and uptake of the MenB vaccine on a large university campus
Human Vaccines & Immunotherapeutics, 2021 Objective: At a large public university, we aimed to evaluate an intervention designed to increase serogroup B meningococcal (MenB) vaccine uptake and awareness.
Eric Richardson +7 more
doaj +1 more source
Impact of serogroup A meningococcal conjugate vaccine for Africa
Human Vaccines & Immunotherapeutics, 2018 The introduction of a serogroup A meningococcal conjugate vaccine in the African meningitis belt has been a remarkable success. Meningitis due to the serogroup A meningococcus, previously responsible for most epidemics, has fallen by 99% in vaccinated ...
James M. Stuart
doaj +1 more source
Insight into Prevention of Neisseria Gonorrhoeae: A Short Review
Vaccines, 2022 Neisseria gonorrhoeae (gonococcus) and Neisseria meningitidis (meningococcus) are important global pathogens which cause the sexually transmitted diseases gonorrhea and meningitis, respectively, as well as sepsis.
Vincenza La Fauci +3 more
doaj +1 more source
Serogroup W-135 Meningococcal Disease during the Hajj, 2000
Emerging Infectious Diseases, 2003 An outbreak of serogroup W-135 meningococcal disease occurred during the 2000 Hajj in Saudi Arabia. Disease was reported worldwide in Hajj pilgrims and their close contacts; however, most cases were identified in Saudi Arabia.
Jairam R. Lingappa +14 more
doaj +1 more source